EXCLUSIVE
Frontiers Pulls Special COVID-19 Issue After Content Dispute
Frontiers Pulls Special COVID-19 Issue After Content Dispute
The issue’s guest editors resign after falling out with the publisher over the management of papers, including a rejected manuscript on ivermectin, that were submitted for a special issue on drug repurposing for COVID-19.
Frontiers Pulls Special COVID-19 Issue After Content Dispute
Frontiers Pulls Special COVID-19 Issue After Content Dispute

The issue’s guest editors resign after falling out with the publisher over the management of papers, including a rejected manuscript on ivermectin, that were submitted for a special issue on drug repurposing for COVID-19.

The issue’s guest editors resign after falling out with the publisher over the management of papers, including a rejected manuscript on ivermectin, that were submitted for a special issue on drug repurposing for COVID-19.

drug repurposing
AI Is Screening Billions of Molecules for Coronavirus Treatments
AI Is Screening Billions of Molecules for Coronavirus Treatments
Abby Olena | May 7, 2020
Machine learning has pegged existing drugs to repurpose for COVID-19 clinical trials.
Alzheimer’s Drug Reduces Chagas Disease Infection in Mice
Alzheimer’s Drug Reduces Chagas Disease Infection in Mice
Emily Makowski | Dec 1, 2019
The drug, called memantine, could enter clinical trials to determine its effectiveness in humans.
Ten-Minute Sabbatical
Ten-Minute Sabbatical
The Scientist Staff | May 1, 2018
Take a break from the bench to puzzle and peruse.
Repurposing Existing Drugs for New Indications
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.
Pharma Redo
Pharma Redo
The Scientist Staff | Dec 31, 2016
Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.